-
Signature
-
/s/ Joseph R. Young, Attorney-in-Fact
-
Issuer symbol
-
VERA
-
Transactions as of
-
03 Dec 2025
-
Net transactions value
-
-$244,700
-
Form type
-
4
-
Filing time
-
04 Dec 2025, 16:05:47 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Turner William D. |
Chief Regulatory Officer |
C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE |
/s/ Joseph R. Young, Attorney-in-Fact |
04 Dec 2025 |
0001819688 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VERA |
Class A Common Stock |
Options Exercise |
$155,300 |
+10,000 |
+44% |
$15.53 |
32,500 |
03 Dec 2025 |
Direct |
|
| transaction |
VERA |
Class A Common Stock |
Sale |
$400,000 |
-10,000 |
-31% |
$40.00 |
22,500 |
03 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VERA |
Stock Option (right to buy) |
Options Exercise |
$0 |
-10,000 |
-3.6% |
$0.000000 |
265,000 |
03 Dec 2025 |
Class A Common Stock |
10,000 |
$15.53 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: